Skip to main content
OpenTrials
Completed

NCT Number: NCT04402983

The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients

Problems such as breathlessness, exercise intolerance and loss of peripheral muscle strength can be observed in individuals who have been diagnosed with COVID19 and have been discharged. In our study, it was aimed to investigate the effect of telerehabilitation physical therapy intervention to these cases by using videoconferencing method on the physical condition of the cases.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 Behavior COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Motor Activity Nidovirales Infections Physical Therapy Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Telerehabilitation Virus Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Health Sciences Turkey

Istanbul, 34668, Turkey (Türkiye)

About this study

Problems such as breathlessness, exercise intolerance and loss of peripheral muscle strength can be observed in individuals who have been diagnosed with COVID19 and have been discharged. In our study, it was aimed to investigate the effect of telerehabilitation physical therapy intervention to these cases by using videoconferencing method on the physical condition of the cases. The exercise program will be a total of 6 weeks, 3 days a week. Online access will be carried out synchronously by telephone or computer, and training sessions will not be recorded in order to protect patient personal information. The cases will be evaluated online at the beginning of the study and at the end of the 6-week exercise program. The selected evaluation parameters have been selected considering the ease of online application.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being between the ages of 18-75
  • Being diagnosed with COVID19 and being discharged by being treated
  • Having technological facilities suitable for telerehabilitation access

Exclusion criteria

  • Any presence of comorbidity that may prevent them from exercising
  • Not agreeing to be included in the study

Treatment and study plan

Physiotherapy

Other

Program content Respiratory exercise (chest breathing, diaphragmatic breathing, basal expansion exercises), Breath control training, Active breathing techniques cycle Light aerobic exercise Posture exercises Self walking

Primary outcomes

  1. Modified Medical Research Council Dyspnea Score

    Time frame: Baseline to 6 weeks

    The mMRC Dyspnea Scale is best used to establish baseline functional impairment due to dyspnea attributable to respiratory disease; tracking the mMRC over time or with therapeutic interventions is of less certain clinical utility.The severity of dyspnea is rated on a scale of 0 to 4. "O" means no dyspnea perception, "4" means severe dyspnea perception.

  2. Timed up and go test

    Time frame: Baseline to 6 weeks

    The Timed "Up and Go" (TUG) Test measures, in seconds, the time taken by an individual to stand up from a standard arm chair (approximate seat height of 46 cm, arm height 65 cm), walk a distance of 3 meters (approximately 10 feet), turn, walk back to the chair, and sit down.

    Normal healthy elderly usually complete the task in 10 seconds or less. Very frail or weak elderly with poor mobility may take 2 minutes or more.

    Clinical guide: <10 seconds = normal <20 seconds = good mobility, can go out alone, mobile without a gait aid <30 seconds = problems, cannot go outside alone, requires a gait aid A score of more than or equal to 14 seconds has been shown to indicate high risk of falls.

  3. Visual analog scale to assess the pain severity

    Time frame: Baseline to 6 weeks

    Visual analog scale to assess the pain on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100) score.

  4. The Short Physical Performance Battery (SPPB)

    Time frame: Baseline to 6 weeks

    The Short Physical Performance Battery (SPPB) is comprised of 3 tasks: a standing balance test (side by side, semi-tandem and tandem), a 4-m habitual gait speed, and 5 sit to stand from a chair. Each task is scored (based on time) from 0-4 points. The total score is 12 points and this represents the highest performance. It can be easily performed at home via video conferencing

  5. Visual analog scale to assess the fatigue severity

    Time frame: Baseline to 6 weeks

    Visual analog scale to assess the fatigue severity on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100) score.

Secondary outcomes

  1. BECK depression inventory

    Time frame: Baseline to 6 weeks

    This is a 21-item self-assessment scale designed by Aaron Beck in 1961 to measure the risk and level of depression.

  2. Saint George Respiratory Questionnaire

    Time frame: Baseline to 6 weeks

    The SGRQ ranges from 0 (no impairment of quality of life) to 100 (highest impairment of quality of life)

Sponsors and collaborators

Lead sponsor

Istanbul Medipol University Hospital

Other

Registry information

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
May 27, 2020
Registry last updated
Dec 14, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.